Abstract variables | Oral (n = 16) | Poster (n = 84) | p value |
---|---|---|---|
Research location in North America | 14 (88%) | 57 (68%) | 0.14 |
Methodological quality | |||
 Randomized | 1 (6%) | 26 (31%) | 0.06 |
 Primary outcome given | 2 (13%) | 24 (29%) | 0.23 |
 Numbers with denominators | 0 (0%) | 6 (7%) | 0.59 |
Ethical quality | |||
 Highest species rodent | 13 (81%) | 48 (57%) | 0.07 |
 Number of animals stated | 3 (19%) | 44 (52%) | 0.02 |
 Number of animals used | 28 (SD 17) | 29 (SD 12) | 0.27 |
Outcomes | |||
 Main outcomes positive | 16 (100%) | 74 (88%) | 0.36 |
 Statistically significant result | 9 (56%) | 46 (55%) | 0.95 |
Type of animal model | |||
 Sepsis | 8 (50%) | 52 (62%) | 0.41 |
 Drug used | 8 (50%) | 53 (63%) | 0.40 |
 Surgery | 11 (69%) | 51 (61%) | 0.59 |
Publication variables | Oral published (n = 14) | Poster published (n = 48) | p value |
---|---|---|---|
Methodological quality | |||
 Randomized | 1 (7%) | 23 (48%) | 0.006 |
 Blinded | 0 (0%) | 4 (8%) | 0.57 |
 Primary outcome given | 0 (0%) | 3 (6%) | 0.99 |
 Numbers with denominators | 3 (21%) | 18 (38%) | 0.35 |
Ethical quality | |||
 Number of animals stated | 4 (29%) | 31 (65%) | 0.03 |
 Number of animals used | 46 (SD 55) | 26 (SD 19) | 0.53 |
Outcomes | |||
 Main outcomes positive | 14 (100%) | 48 (100%) | 0.99 |
 Statistically significant result | 13 (93%) | 45 (94%) | 0.99 |
Journal factors | |||
 Journal impact factor | 5.1 (SD 3.2) | 5.3 (SD 5.3) | 0.92 |
 Months to publication | 31 (SD 23) | 20 (SD 14) | 0.12 |